Related Experiment Video
Updated: Jul 26, 2026
12:21
Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells
Published on: March 3, 2016
10.3K
Precision Drug Repurposing: A Deep Learning Toolkit for Identifying 34 Hyperpigmentation-Associated Genes and
Shuwei Chen1, Junhao Zeng1, Mariam Saad2
1From the Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Annals of Plastic Surgery
|June 19, 2024
Summary
This study used computational methods to identify new targeted therapies for hyperpigmentation. Advanced analysis pinpointed key genes and recommended 29 potential drugs, offering novel treatment avenues for skin hyperpigmentation.
Area of Science:
- Computational biology
- Dermatology
- Pharmacology
Background:
- Hyperpigmentation involves increased melanin production, leading to skin darkening.
- Current secondary treatments like chemical peels and lasers carry risks, including post-inflammatory hyperpigmentation.
- Novel therapeutic strategies are needed to address treatment-resistant hyperpigmentation.
Purpose of the Study:
- To investigate computational methods for identifying novel targeted therapies for hyperpigmentation.
- To pinpoint key genes associated with hyperpigmentation using integrated bioinformatics approaches.
- To identify potential drug candidates for hyperpigmentation treatment through drug-gene interaction analysis.
Main Methods:
- Integrated text mining to identify hyperpigmentation-related genes.
- Utilized GeneCodis, STRING, and Cytoscape for gene enrichment and protein-protein interaction analysis.
- Employed Cortellis and DeepPurpose for drug-gene interaction and drug-target prediction.
Main Results:
- Identified 34 hyperpigmentation-related genes via text mining.
- Eight key genes were highlighted through integrated bioinformatics analyses.
- Discovered 35 drugs targeting associated genes, with 29 recommended by DeepPurpose, including M2PK1, KRAS, and BRAF inhibitors.
Conclusions:
- Advanced computational methodologies show promise for identifying novel hyperpigmentation treatments.
- The study successfully identified potential drug candidates for hyperpigmentation.
- This approach offers a new direction for developing targeted therapies for skin hyperpigmentation.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...